Warning: Creating default object from empty value in /home/cannabisscience/public_html/plugins/system/t3/base-bs3/html/com_content/category/default_articles.php on line 17

Title	Published Date
Cannabis Science Identifies Another Urgent Need for Its Pharmaceutical Products as Suicides and Sudden Deaths Among Vets With Post Traumatic Stress Disorder Linked to a Number of Widely-Prescribed FDA Approved Pharmaceuticals Such as Seroquel and Other An	20-05-10
Cannabis Science Acquires Two Revenue Producing Operations, a Medical Marijuana Growing Facility and a Dispensary to Facilitate Operational Growth, Research and Development of Pharmaceutical Cannabis Products in Colorado in Accordance With State Laws	24-05-10
Cannabis Reports on Bloomberg News, 15 Members of Congress Led by Representative Barney Frank Support Dispensaries as Legitimate Businesses; Cannabis Science Value Increased for Pharmaceutical Research and Development; New Colorado Law Adds Protection	25-05-10
Cannabis Science President and CEO Dr. Robert Melamede, PhD., Files Preliminary Patent Disclosures With the University of Colorado Regarding New Technology That Cannabis Science Intends to Develop Through a Private Company Acquisition	01-06-10
Cannabis Science Anticipates Marijuana Legalization as Latest Polls Show Legalization Leading 49% in Favor With 41% Opposed; Los Angeles City Efforts to Close Medical Dispensaries Will Help Drive to End Prohibition	08-06-10
CBIS Announces Federal Court Order for CBIS Shares Owned by Cannex Therapeutics Controlled by Steve Kubby to be Cancelled and Re-Issued to K&D Equity Investments Inc.	15-06-10
Cannabis Science Jumps With Its Next Acquisition; Montana Pain Management, Inc., One of the Leading Medical Marijuana Providers in the State of Montana	17-06-10
Montana Governor Brian Schweitzer Visits New Cannabis Science Acquisition	18-06-10
Governor Schweitzer's Visit to Cannabis Science Acquisition, Montana Pain Management, Draws Extensive Media Coverage; Governor "Impressed by the Sophistication" of Operation Model for New State Regulations	23-06-10
Cannabis Science Reports Important Validation for Medical Cannabis as Bayer Pays '$15 Million Milestone Payment' for GW Pharmaceuticals' Sativex(R) for MS, as the UK Government Approves "First Prescription Cannabis Medicine"	28-06-10

• Start
• Prev
• 1
• 2
• 3
• 4
• 5
• Next
• End